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Abstract
A systems understanding of nuclear organization and events is critical for determining how cells divide, differentiate, and
respond to stimuli and for identifying the causes of diseases. Chromatin remodeling complexes such as SWI/SNF have been
implicated in a wide variety of cellular processes including gene expression, nuclear organization, centromere function, and
chromosomal stability, and mutations in SWI/SNF components have been linked to several types of cancer. To better
understand the biological processes in which chromatin remodeling proteins participate, we globally mapped binding
regions for several components of the SWI/SNF complex throughout the human genome using ChIP-Seq. SWI/SNF
components were found to lie near regulatory elements integral to transcription (e.g. 59 ends, RNA Polymerases II and III,
and enhancers) as well as regions critical for chromosome organization (e.g. CTCF, lamins, and DNA replication origins).
Interestingly we also find that certain configurations of SWI/SNF subunits are associated with transcripts that have higher
levels of expression, whereas other configurations of SWI/SNF factors are associated with transcripts that have lower levels
of expression. To further elucidate the association of SWI/SNF subunits with each other as well as with other nuclear
proteins, we also analyzed SWI/SNF immunoprecipitated complexes by mass spectrometry. Individual SWI/SNF factors are
associated with their own family members, as well as with cellular constituents such as nuclear matrix proteins, key
transcription factors, and centromere components, implying a ubiquitous role in gene regulation and nuclear function. We
find an overrepresentation of both SWI/SNF-associated regions and proteins in cell cycle and chromosome organization.
Taken together the results from our ChIP and immunoprecipitation experiments suggest that SWI/SNF facilitates gene
regulation and genome function more broadly and through a greater diversity of interactions than previously appreciated.
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Introduction
Chromosomes undergo a wide variety of dynamic processes
including transcription, replication, repair and packaging. Each of
these activities requires the recruitment and congregation of a
particular set of factors and chromosomal elements. For example
visualization of nascent mRNA in HeLa cells has led to a model of
transcription units being clustered into ‘‘factories’’ thereby
facilitating optimal engagement of RNA Polymerase II (Pol II)
and coordination with other crucial holoenzyme complexes [1–3].
In addition to RNA Pol II and transcription factors, transcriptional
assemblages include proteins critical to regulating chromatin. The
accessibility of nuclear proteins to DNA is often controlled by
ATP-dependent chromatin remodeling complexes, which are
thought to play a role in a number of different cellular transactions
by reshaping the epigenetic landscape.
The SWI/SNF (switch/sucrose nonfermentable) chromatin
remodeling proteins were first discovered in Saccharomyces cerevisiae
as components of a 2 MDa complex that repositions nucleosomes
for vital tasks such as transcriptional control, DNA repair,
recombination and chromosome segregation [4,5]. Mammalian
SWI/SNF is comprised of approximately ten subunits and the
combinations of these subunits, some of which have multiple
isoforms, enable multiple varieties of SWI/SNF complexes to exist
both within a given cell and across cell types [6]. Among these
subunits either of the two ATPases, Brg1 or Brm, is sufficient to
remodel nucleosome arrays in vitro, however maximal nucleosome
remodeling activity is achieved when the SWI/SNF subunits
BAF155, BAF170 and Ini1 are present in a 2:1 stoichiometry
relative to Brg1 [7]. Whereas the ATPases have an obvious
catalytic function, the roles of the other SWI/SNF subunits are
largely obscure. Several reports indicate that BAF155 and BAF170
provide scaffolding functions for other SWI/SNF subunits as well
as regulating their protein levels [8,9]. SWI/SNF also contains b-
actin and the actin-related protein BAF53, suggesting a possible
bridge to nuclear organization or signal transduction, e.g. through
phosphatidylinositol signaling [10,11]. Phosphatidylinositol 4,5-
bisphosphate has been shown to bind to Brg1 and promote
PLoS Genetics | www.plosgenetics.org 1 March 2011 | Volume 7 | Issue 3 | e1002008binding to actin filaments [12]. Mutations resulting in loss of Ini1
function are associated with rare but aggressive pediatric cancers
[13,14]. The SWI/SNF subunits Brg1 [15] and ARID1A [16–18]
are likewise thought to have tumor suppressor roles based on
mutations recovered from other tumor types. Curiously, Ini1 alone
has a unique and largely undefined role in HIV-1 infection that
includes binding of Ini1 to HIV-1 integrase and the cytoplasmic
export of Ini1 and its incorporation into HIV-1 particles [19–21].
The role of SWI/SNF components in cancer and tumor
suppression is poorly understood despite extensive study. Detailed
investigations of individual loci have implicated SWI/SNF in
various transcriptional pathways including the cell cycle and p53
signaling [22], insulin signaling [23], and TGFb signaling [24], as
well as signaling through several different nuclear hormone
receptors [25]. Although in vitro experiments and single-gene
studies have been informative and have laid the foundation for
understanding chromatin remodeling, a global analysis of targets
of SWI/SNF is expected to yield a more extensive view into the
biological roles of SWI/SNF components and their involvement in
human disease.
In this study we present two complementary global analyses of
SWI/SNF subunits to provide a more systematic view of SWI/
SNF functions. First we performed ChIP-Seq with the ubiquitous
SWI/SNF components Ini1, BAF155, BAF170 as well as the Brg1
ATPase. Second, in a parallel set of studies we performed mass
spectrometry identification of proteins that co-immunoprecipitate
with SWI/SNF components. Using our ChIP-Seq results the
resulting chromosomal locations were integrated with published
annotations to yield a more complete understanding of SWI/SNF
on a genome-wide scale. We find SWI/SNF components
frequently occupy transcription start sites (TSSs), enhancers,
CTCF regions and many regions occupied by Pol II. Further
analyses of the SWI/SNF regions we identified by ChIP-Seq
reveals that SWI/SNF factors target genes and signaling pathways
involved in cell proliferation and cancer. Our investigation of
SWI/SNF protein interactions detected not only the expected co-
occurrences of individual SWI/SNF factors with each other but
also with cellular components such as nuclear matrix proteins, key
transcription factors and centromere proteins implying a ubiqui-
tous role in gene regulation and nuclear function. We find an
overrepresentation of both SWI/SNF-associated chromosomal
regions and proteins in cell cycle and chromosome organization.
Collectively our results suggest that SWI/SNF is at the nexus of
multiple signal transduction pathways, essential chromosomal
functions and nuclear organization.
Results
Genome-wide mapping of SWI/SNF subunits reveals
many different co-associations
We identified the targets of four SWI/SNF components, Ini1
(SMARCB1), Brg1 (SMARCA4), BAF155 (SMARCC1) and
BAF170 (SMARCC2), using ChIP-Seq. Chromatin complexes
were isolated from HeLa S3 nuclei following independent
immunoprecipitations with antibodies for each factor. Each of
these antibodies was characterized by both immunoblot and mass
spectrometry analyses (see Materials and Methods). Reads that
mapped uniquely to the genome were retained (29–33 million
reads per data set; Table1) and significant binding regions were
identified using the PeakSeq program with q-value,0.05 [26].
The peaks were compared to a similarly-sized data set of uniquely
mapped ChIP DNA reads obtained from control immunoprecip-
itation experiments using normal IgG (i.e. a control serum that is
not directed to any known antigens). Using this approach we
identified many Ini1-, Brg1-, BAF155- and BAF170-associated
regions (Table1).
The majority of SWI/SNF binding occurs near (62.5 kb)
protein-coding genes, a distribution that is significant relative to a
random target list (p,1610
216; Genome Structure Correction
(GSC) test [27]; see Materials and Methods). Several examples of
SWI/SNF positioning relative to genic regions are shown in
Figure1 and Figure S1. In order to further examine SWI/SNF
locations with respect to gene-rich and gene-poor regions we
obtained a set of histone H3K27me3 domains that were identified
in HeLa cells (Table S1; [28]) because this chromatin mark often
occurs in gene-poor and repressed (i.e. heterochromatin) regions.
Although most SWI/SNF-binding occurs outside H3K27me3
domains, we observed that SWI/SNF is occasionally found in
heterochromatin regions, as shown in Figure2. In this example a
7.5 Mb heterochromatin region on Chr16 contains a single gene,
the neuronal cadherin CDH8, that is repressed and lacks RNA Pol
II, however several SWI/SNF binding regions are found nearby.
We have performed considerable analyses of the targets for the
individual SWI/SNF factors, particularly with respect to elements
representing several major classes of genomic features including
promoters (Ensembl protein-coding genes), RNA Pol II sites [26],
CTCF sites [28], and predicted enhancers [29]. All of these
features were identified in HeLa cells (Table1, Tables S1 and S2;
see Materials and Methods). In comparisons between the
individual target lists for Ini1, Brg1, BAF155 and BAF170 with
promoters, RNA Pol II sites, CTCF sites and enhancers we found
that each SWI/SNF factor is significantly overrepresented for each
of these major classes of genomic elements (p,1610
216, GSC test,
see Materials and Methods). To arrive at a single unified and more
conservative list of SWI/SNF locations, we first took the union of
all regions for Ini1, BAF155, BAF170 and Brg1, resulting in
69,658 SWI/SNF regions. We then trimmed this list to a high-
confidence set of 49,555 sites by eliminating those regions where
either only a single SWI/SNF subunit was present or that those
regions that did not co-occur with either promoters, RNA Pol II
sites, CTCF sites or predicted enhancers. We used this list of
49,555 SWI/SNF regions for all subsequent analyses unless
otherwise noted (Table S3). The four major classes of genomic
Author Summary
Genetic information and programming are not entirely
contained in DNA sequence but are also governed by
chromatin structure. Gaining a greater understanding of
chromatin remodeling complexes can bridge gaps be-
tween processes in the genome and the epigenome and
can offer insights into diseases such as cancer. We
identified targets of the chromatin remodeling complex,
SWI/SNF, on a genome-wide scale using ChIP-Seq. We also
identify proteins that co-purify with its various compo-
nents via immunoprecipitation combined with mass
spectrometry. By integrating these newly-identified re-
gions with a combination of novel and published data
sources, we identify pathways and cellular compartments
in which SWI/SNF plays a major role as well as discern
general characteristics of SWI/SNF target sites. Our parallel
evaluations of multiple SWI/SNF factors indicate that these
subunits are found in highly dynamic and combinatorial
assemblies. Our study presents the first genome-wide and
unified view of multiple SWI/SNF components and also
provides a valuable resource to the scientific community
as an important data source to be integrated with future
genomic and epigenomic studies.
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SWI/SNF regions as well as the more conservative list 49,555
SWI/SNF regions (p,1610
216, GSC test).
We next examined the configurations of our 49,555 SWI/SNF
regions (Figure3A and Table2). Ini1, BAF155 and BAF170 have
been described as forming a ‘core’ based on their ability to
stimulate remodeling activity of the Brg1 ATPase in reconstitution
experiments [7]. Among our data 30,310 regions (61%) have two
or more SWI/SNF components and 9,760 regions (20%) contain
the core of Ini1, BAF155 and BAF170; for the purposes of this
study we call this the ‘core set’. Among putative complexes
comprised of two or more SWI/SNF subunits, we observed
BAF155 was the subunit most common to each binding region.
Only 770 SWI/SNF subunit co-occurrences were recovered that
lacked BAF155 as compared to 6,467 for BAF170 and 14,824 for
Ini1. This finding is consistent with several previous studies
showing that BAF155 is important for SWI/SNF complex stability
[8,9]. BAF155 may increase the stability of the complex during
assembly, or BAF155 may be easier to detect by ChIP.
Genome-wide locations of SWI/SNF components suggest
diverse roles in gene regulation
One of the primary functions of chromatin remodeling
complexes is to assist in gene regulation. Among the SWI/SNF
regions in our high-confidence union set of 49,555 sites, 29%
correspond to the 59 ends of protein-coding Ensembl genes, 40%
correspond to Pol II sites, 17% correspond to CTCF sites and 43%
correspond to predicted enhancer regions (Figure3B; Table3). The
various combinations of these four elements account for a total of
90% of the SWI/SNF union regions; 4,800 (10%) of the SWI/
SNF regions are unclassified using the above elements. Similar
trends were observed for the 9,760 SWI/SNF ‘‘core’’ regions
where Ini1, BAF155 and BAF170 all co-occur (Table3). None of
these four particular SWI/SNF subunits or any combinations
thereof exhibited a differential preference for one type of element
(Table S4).
There are some differences between the SWI/SNF core and
union regions. The SWI/SNF core regions are overrepresented for
RNA Pol II (p,9.9610
216; hypergeometric test) and 59 ends
(p,6.5610
2211; hypergeometric test) relative to all of the SWI/
SNF high-confidence union regions; however the SWI/SNF high-
confidence union regions are overrepresented for enhancer regions
relative to the Ini1-BAF155-BAF170 core (p,2.4610
267;
hypergeometric test). Neither the SWI/SNF core nor the high-
confidence union regions were over- or underrepresented for
CTCF sites relative to each other (p.0.05; hypergeometric test).
Enhancers are often characterized by long-range interactions.
We examined the locations of SWI/SNF binding regions in the
150 kb CIITA region where numerous chromosomal looping
interactions have been mapped at high resolution in HeLa cells
using 3C (Chromosome Conformation Capture). Brg1 has been
previously mapped at several sites in this locus in these cells [30].
Superimposition of these 3C data on our SWI/SNF ChIP-Seq
data (Figure4) reveals that all six of the 3C interacting regions in
the CIITA locus (250 kb, 216 kb, 28 kb, pIV, +40 kb and
+59 kb) are bound by SWI/SNF components. Moreover certain
individual SWI/SNF component binding regions that appeared
initially as orphans may now be seen as part of a complete
complex when joined with a distal element. For example Ini1 at
pIV when joined with BAF155 and BAF170 regions at the 216 kb
element forms a SWI/SNF core. Thus in the CTIIA locus SWI/
SNF regions are often associated with 3C regions and many of the
regions bound by individual factors may in fact be part of entire
SWI/SNF complexes inside the nucleus.
Overall our ChIP-Seq results are summarized in Table1,
Table2, Table3, and Figure3 and indicate that SWI/SNF likely
contributes to gene regulation through many different avenues in
light of its binding to promoters, enhancers and CTCF sites.
Furthermore SWI/SNF may facilitate looping interactions among
these various elements as it has been shown in vitro that SWI/SNF
can interact simultaneously with multiple DNA sites and generate
loops between them [31]. Interestingly we found a slightly higher
presence of the SWI/SNF core at TSSs and with Pol II than the
SWI/SNF union regions with these elements (Table3). Thus a
complete core of Ini1, BAF155 and BAF170 may be required for
effective promoter function whereas only a subset of these factors
may be required for enhancer function. Alternatively a full SWI/
SNF core may be more difficult to recover from a single enhancer
element as compared to a more compact promoter region due to
the enhancer’s presumed interaction with many different distal
elements.
RNA polymerases are extensively colocalized with SWI/
SNF
As detailed above SWI/SNF regions are enriched for Pol II. To
explore the prevalence of SWI/SNF with transcriptional machin-
Table 1. Read counts and target regions identified by ChIP-Seq.
Data set
Number of uniquely
mapped reads
Total number of
targets (PeakSeq)
1
Number of
genic targets
2
Number of targets
after filtering (high-
confidence union)
3
Ini1 33,360,976 49,458 32,725 (66%) 24,478 (49%)
Brg1 30,037,219 12,725 7,823 (61%) 12,317 (25%)
BAF155 28,800,740 46,412 28,221 (61%) 37,921 (77%)
BAF170 29,090,374 30,136 18,847 (63%) 25,433 (51%)
Pol II 29,060,928 23,320 18,305 (78%) 19,669 (40%)
IgG control 28,960,961 N/A N/A N/A
1 Uniquely mapped targets were identified by PeakSeq and further filtered using criteria more stringent than the default parameters. See Materials and Methods.
2 Genic regions were identified for the total number of targets determined by PeakSeq. Genic regions are defined as a window encompassing 2.5 kb up- and
downstream of the 59 and 39 ends, respectively, using protein-coding genes from Ensembl build 52 based on hg18.
3 The high-confidence union list contains 49,555 targets and was formed by creating a union list of all SWI/SNF regions from those identified by PeakSeq and trimming
this list to those SWI/SNF regions that co-occur with each other, Pol II regions, 59 ends of protein-coding genes, CTCF sites or putative enhancers. For further details, see
Materials and Methods.
doi:10.1371/journal.pgen.1002008.t001
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regions bound by RNA polymerases are enriched for SWI/SNF.
Indeed Pol II regions are enriched for SWI/SNF binding regions
(p,1610
216, GSC test). Although Pol II overlaps extensively with
SWI/SNF it differs from SWI/SNF in its concordance with
CTCF and enhancer regions (Table S5). Pol II regions lacking
SWI/SNF show a five-fold decrease in CTCF sites and a two-fold
decrease in enhancer regions as compared to those Pol II regions
containing SWI/SNF.
We further compared our SWI/SNF regions with binding
intervals identified for RNA polymerase III (Pol III), which in
addition to transcribing tRNA and other non-protein coding
RNAs has an emerging role in the formation of boundary elements
[32,33]. Pol III localization data were obtained from published
ChIP-Seq studies using HeLa cells ([34,35]; Tables S1 and S6) and
constitute 478 known and novel Pol III-associated regions. Pol II is
often associated with Pol III (Table4; reviewed in [32]. Therefore
we examined whether SWI/SNF was associated with Pol III
binding regions independently of Pol II. Of the 478 Pol III regions,
253 Pol III intervals lack Pol II and among these 39% (98/253)
contain one or more SWI/SNF components. These results suggest
that SWI/SNF association with Pol III can occur independently of
Pol II.
Overall 65% (309/478) of Pol III regions and 84% (19,541/
23,320) of Pol II regions have at least one SWI/SNF factor
associated with them. The Ini1-BAF155-BAF170 core is found at
41% (195/478) of Pol III regions and 52% (12,079/23,320) of Pol
II regions. From the colocalizations of SWI/SNF, Pol II and Pol
III we see that there is substantial overlap among these factors yet
each of these factors also has distinct characteristics.
SWI/SNF components bind near many expressed regions
SWI/SNF is known to act as both an activator and repressor of
transcription [36]. We examined the locations of four SWI/SNF
Figure 2. SWI/SNF signals and target regions in the context of H3K27me3 domains. As shown in panel A SWI/SNF signals (blue) are sparse
in H3K27me3 regions (yellow) along the entire length of chromosome 16. An exception is shown in Panel B where SWI/SNF occurs around the CDH8
gene that is embedded in a H3K27me3 domain. CDH8 encodes a brain-expressed cadherin that is not expressed in HeLa cells using the data of Morin
et al.
doi:10.1371/journal.pgen.1002008.g002
Figure 1. SWI/SNF regions co-occur with many diverse genomic elements. The ChIP-Seq regions and signal tracks displayed encompass a
,340 kb region on chromosome 6. The coordinates shown are in hg18 and all regions were identified in HeLa cells as detailed in Table S1 and
Materials and Methods. Insets A–D are shown both in the context of the 340 kb region and in magnified view. Inset A displays a ,10 kb region at the
edge of a H3K27me3 domain. Inset B displays a ,10 kb region around the 59 end of FOXP4. Inset C displays a ,20 kb region around the 59 end of
MDFI. Inset D shows an example of where lamin A/C and lamin B can both flank and overlap with each other. Annotations above the coordinate axis
are for forward-strand genes, and annotations below are for reverse-strand genes. Signal tracks are scaled consistently based on number of reads. The
vertical axis for each signal track is the count of the number of overlapping DNA fragments at each nucleotide position and is scaled from 0 to 40 for
each track.
doi:10.1371/journal.pgen.1002008.g001
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the RNA-Seq data of Morin et al. [37], Ini1, Brg1, BAF155 and/
or BAF170 are present at or near the 59 ends (62.5 kb) of 71 to
92% of active protein-coding genes. As noted above, SWI/SNF
occupancy in promoters is similar to that of Pol II and each of the
factors is individually enriched in promoter regions (p,1610
216,
GSC test). Although the majority of Ini1, Brg1, BAF155 and
BAF170 target genes are expressed, an appreciable fraction of
gene targets have little or no detectable mRNA in HeLa cells. A
closer examination of the union regions where a SWI/SNF
component is located in the promoter of an inactive gene reveals
that 58% (2,063/3,565) of these promoters are co-associated with
Pol II suggesting transcriptional stalling (reviewed in [38,39].
Considering that SWI/SNF components bind near many
expressed regions and that SWI/SNF factors occur in a multitude
of configurations (Figure3 and Table S3), we examined transcript
expressionlevelsforallpossiblecombinationsofIni1,Brg1,BAF155
and BAF170 occurrences. Using the RNA-Seq data of Morin et al.
[37], we examined transcript expression levels corresponding to
each of these configurations (Figure5). We see that the highest levels
of transcription are associated with the following four configura-
tions: 1) the complete core of Ini1, BAF155 and BAF170; 2) the
complete core plus Brg1; 3) Ini1 and BAF155 only and 4) Brg1,
BAF155 and BAF170. Although BAF155 is the subunit that is
common to all of the configurations associated with the highest
levels of transcription, it does not appear to be the sole driver of
transcriptional activity. Compared against each other, all three
components of the core complex taken individually have nearly
indistinguishable profiles. Despite the involvement of Brg1 in two of
thefourconfigurationswiththehighestexpression levels, most other
configurations involving Brg1 are restricted to profiles associated
with the lowest expression levels. One inference from these data is
that certain combinations of SWI/SNF subunits are likely
synergistic in promoting transcription whereas other combinations
may be inhibitory or unstable.
We also examined SWI/SNF occurrences relative to 48,403 non-
canonical small RNAs from HeLa cells (#156 bp; Table S1) where
most (83%; p,1610
216, GSC test) of these small RNAs are near
protein-coding genes [40]. Approximately one third (30%) of this entire
small RNA set is within 1 kb of a target from our high-confidence
union list of 49,555 SWI/SNF regions. The incidence of small RNA-
SWI/SNF co-associated regions was nearly equivalent in protein-
coding genes and intergenic regions. From this we surmise that SWI/
SNF may contribute to gene regulation of a variety of transcripts, many
of which are newly annotated and of unknown function.
SWI/SNF targets genes involved in nuclear function and
cancer pathways
Prior research has shown that a variety of signaling cascades are
linked to SWI/SNF [25]. To gain further insights into potential
actions of SWI/SNF components we examined the underlying
Gene Ontology (GO) and Kyoto Encyclopedia of Genes and
Genomes (KEGG) designations of their gene targets to determine
significantly overrepresented annotations and pathways (Table5
and Table S8). SWI/SNF gene targets were associated with
Figure 3. Venn diagrams showing overlaps for the SWI/SNF union target regions. Panel A displays the various combinations of all Ini1,
BAF155, BAF170 and Brg1 targets in the 49,555 high-confidence union regions (see also Table2). Panel B displays the various combinations of Pol II
regions, 59 ends of Ensembl protein-coding genes, CTCF sites and putative enhancers occurring in the 49,555 SWI/SNF high-confidence union target
regions. Of the 49,555 high-confidence union regions, 4,800 (10%) do not contain any of these elements and are defined as ‘‘unclassified’’ (Table3).
doi:10.1371/journal.pgen.1002008.g003
Table 2. Combinations of SWI/SNF factors found in the high-
confidence union regions.
SWI/SNF Union Set 49,555
Two or more subunits 30,310
Three or more subunits 15,535
Core Set: Ini1, BAF155 and BAF170 (may include Brg1) 9,760
Ini1, BAF155, BAF170 and Brg1 4,750
doi:10.1371/journal.pgen.1002008.t002
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myeloid leukemia and pancreatic cancer. A number of signaling
pathways and cellular processes that are ‘‘hallmarks of cancer’’ [41]
were also overrepresented among the gene targets of Ini1, Brg1,
BAF155 and BAF170. These include the Wnt, ErbB, p53, MAPK,
and insulin signaling pathways, and processes endemic to
oncogenesis and cancer progression such as DNA repair, the cell
cycleandapoptosis.Fromtheseanalyseswesurmise the recruitment
ofSWI/SNFcomponentsislikelyto influencethemolecular basisof
cancer through several potential mechanisms.
The SWI/SNF-enriched pathways are highly interconnected.
Using the 49,555 SWI/SNF targets we identified a total of 24
KEGG signaling or biochemical pathways (Figure6, yellow nodes).
Interestingly, these pathways partition into three groups
(Figure6A–6C). Two of the groups (Figure6A and 6B) comprise
sets of pathways exhibiting at most one degree of separation, e.g.
‘inositol phosphate metabolism’ and ‘amino sugar and nucleotide
sugar metabolism’. The third group (Figure6C) consists of three
pathways that are unrelated to any other pathways in the KEGG
database. As displayed in Figure S2 directly related pathways such
as ‘p53 signaling’ and the ‘cell cycle’ have shared components and
many of the genes encoding these components are occupied by
SWI/SNF factors. Thus, our results demonstrate that SWI/SNF is
involved in many closely related signaling pathways and cellular
processes and may help serve to coordinate expression of genes
involved in these processes.
Table 3. Genomic elements found in SWI/SNF target regions.
Genomic Elements SWI/SNF union set (49,555 regions total)
1 SWI/SNF core set (9,760 regions total)
2
CTCF, Pol II, Enhancers, 5’ ends (any combination) 44,755 (90%) 8,968 (92%)
Unclassified 4,800 (10%) 792 (8%)
RNA Pol II sites 19,669 (40%) 6,562 (67%)
Putative Enhancers 21,228 (43%) 3,431 (35%)
CTCF sites 8,542 (17%) 1,692 (17%)
5’ ends (within 2.5 kb) of Ensembl protein-coding genes 14,291 (29%) 4,089 (42%)
1 This high-confidence union list is the same described in Table1. For further details see Materials and Methods.
2 The core set is defined as those regions having a co-occurrence of Ini1, BAF155 and BAF170.
doi:10.1371/journal.pgen.1002008.t003
Figure 4. SWI/SNF signals relative to 3C (Chromosome Conformation Capture) sites in the CIITA locus. A ,150 kb region surrounding
the CIITA locus is shown with SWI/SNF signals. Chromosomal loops detected in Ni et al. [30] are displayed as brackets connecting regions that were
shown to contact each other using 3C. In the absence of c-interferon eight constitutive contacts have been observed by 3C in HeLa cells between the
sites at: (250:28), (250:+59), (28:+59), (pIV:+40), (250:pIV), (216:pIV), (28:+40) and (28:pIV). CIITA contains STAT1 binding regions; for comparison,
STAT1 data are also shown from ChIP-Seq signals and target regions obtained from c-interferon-stimulated HeLa cells as we previously reported [26].
The Ini1 site at pIV, when joined with BAF155 and BAF170 regions at the 216 kb element, forms complete a SWI/SNF core. The vertical axis for each
signal track is the count of the number of overlapping DNA fragments at each nucleotide position and is scaled from 0 to 40 for each track.
doi:10.1371/journal.pgen.1002008.g004
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multiple aspects of gene regulation and are nodes in a
highly integrated network
The genomic binding data demonstrates that SWI/SNF
localization is coupled with a broad range of functional elements,
suggesting that SWI/SNF may also be found with a broad range of
associated proteins. To further examine the scope of SWI/SNF’s
roles in the nucleus we analyzed proteins associated with SWI/
SNF subunits using co-immunoprecipitation followed by mass
spectrometry. The SWI/SNF components Ini1, BAF155,
Table 4. Co-occurrence of RNA Pol II and Pol III with SWI/SNF high-confidence union regions.
All RNA Pol III
1 All RNA Pol II
2
SWI/SNF, Pol II
and Pol III
3
SWI/SNF and
Pol III present;
Pol II absent
4
Pol III present
and SWI/SNF
absent
5
Pol II present
and SWI/SNF
absent
6
RNA Pol III 478 182 (0.8%) 211 98 169 6 (,0.1%)
RNA Pol II 225 (47%) 23,320 211 0 14 (8%) 3,779
Ini1 274 (57%) 18,674 (80%) 201 (95%) 73 (74%) 0 0
BAF155 235 (49%) 16,175 (69%) 176 (83%) 59 (60%) 0 0
BAF170 248 (52%) 12,790 (55%) 179 (85%) 69 (70%) 0 0
Brg1 75 (16%) 7,303 (31%) 68 (32%) 7 (7%) 0 0
Core 195 (41%) 12,079 (52%) 160 (76%) 35 (36%) 0 0
CTCF 49 (10%) 2,448 (10%) 14 (7%) 25 (26%) 10 (6%) 68 (,2%)
Enhancer 22 (5%) 4,527 (19%) 4 (2%) 14 (14%) 4 (2%) 377 (10%)
Protein-coding
7 198 (41%) 18,305 (78%) 111 (53%) 34 (35%) 53 (31%) 3,052 (81%)
1 There are a total of 478 Pol III regions genome-wide.
2 There are a total of 23,320 Pol II regions genome-wide.
3 SWI/SNF, Pol II and Pol III co-occur in 211 regions. Percentages shown are relative to these 211 regions.
4 Pol III co-occurs with 98 SWI/SNF regions in the absence of Pol II.
5 Of the total 478 Pol III regions 169 lack SWI/SNF.
6 Of the total 23,320 Pol II regions 3,779 lack SWI/SNF.
7 Regions within 2.5 kb of an Ensembl protein-coding gene.
doi:10.1371/journal.pgen.1002008.t004
Figure 5. Violin plots of expression values across all possible SWI/SNF subunit occurrences. Violin plots display the probability density
function plotted against the adjusted depth (i.e. expression) values from Morin et al [37]. Transcript counts for each category are given in Table S7. We
find that some combinations of subunits are associated with transcripts with higher expression levels while other combinations are associated with
transcripts with lower expression levels.
doi:10.1371/journal.pgen.1002008.g005
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HeLa S3 nuclei, the resulting proteins were gel-separated and
peptides were generated for analysis by mass spectrometry (See
Materials and Methods; Table S9). In addition to the factor-
specific antibodies, parallel immunoprecipitations were performed
using non-specific IgG antibodies. Proteins identified in these
‘‘control IgG’’ immunoprecipitations were excluded as potential
SWI/SNF co-purifying factors.
We identified a total of 101 proteins that were specifically
associated with at least one of the SWI/SNF components assayed
(Figure7, turquoise edges; Table S10). Of the non-SWI/SNF
subunits detected, 5 of these interactions were found previously in
HeLa cells (e.g. estrogen receptor alpha [42], and 96 were new to
this study. Interestingly one of the novel interactions we observed
in HeLa cells, BAF155 with NUF2, has been previously observed
in yeast between the yeast homolog of BAF155 (SWI3) and NUF2
[15]. Using the 101 nodes that we identified as proteins co-
purifying with SWI/SNF in our undirected approach we
ascertained overrepresented GO categories (Table6). Several of
these designations such as ‘cell cycle’ and ‘chromosome organi-
zation’ coincide with the categories obtained from GO and
pathway analyses of SWI/SNF ChIP-Seq targets, suggesting the
possibility of highly-interactive network structures.
Many of the proteins that were novel to this study reinforce and
expand upon other published reports of SWI/SNF characteriza-
tions. For example SWI/SNF components have been localized by
immunofluorescence to mitotic kinetochores and spindle poles
[43], and Brg1-deficient mice show dissolution of pericentromeric
heterochromatin domains [44]. From our immunoprecipitations
BAF155 and BAF170 were associated with a number of
kinetochore and centrosomal proteins (e.g. BUB1B, CENPE and
NUF2, Figure8, green circles). The role of SWI/SNF in the
maintenance of kinetochore and spindle function is unknown. We
detected a variety of transcription factor activators and repressors
(e.g. NFkB1, NFkB2, RelA, PML and NFX1) as well as DNA
repair (ERCC5 and RAD50) and cell cycle (e.g. CCNB3 and
CDCA2) proteins (Figure S3). Some of the SWI/SNF interacting
proteins themselves interact with one another. For example we
detected several different proteins integral to estrogen and insulin
signaling (Figure7; Table S10). We also identified proteins
associated with only one SWI/SNF factor; these may either be
interactions with a specific SWI/SNF component or an inability to
detect the protein in the immunoprecipitations.
We developed an expanded network of SWI/SNF associations
by including proteins that were found by others to co-purify with
SWI/SNF subunits (Figure7, black edges). Only those factors that
showed a one-degree separation with a SWI/SNF component in
HeLa cells are displayed and all interactions are annotated in
Table S10. SWI/SNF interacting proteins are associated with
numerous UniProt keywords (Figure8; [45]). Overall these results
suggest a role for SWI/SNF components in a wide array of nuclear
processes and diseases. Some of these processes may take place in
nuclear substructures. Higher order chromatin structure is
facilitated by the nuclear lamina and tethering of genes to the
nuclear periphery is one epigenetic mechanism of gene regulation
[46,47]. Intriguingly we and others have detected SWI/SNF
components with various nuclear envelope-associated proteins
(Figure7 and Table S10) including lamin A, EMD (emerin) and
BAF/BANF1 (Barrier to Autointegration Factor, which although
similar in name is not a SWI/SNF subunit). Two of the nuclear
membrane proteins, SYNE1 and C14orf49, that we isolated in
association with BAF155 are part of LINC complexes that link the
nucleoskeleton and cytoskeleton [48,49].
A fraction of SWI/SNF regions are associated with the
nuclear lamina
Numerous studies point to a high degree of functional
organization in cell nuclei [46]. Emerging nuclear organization
models would benefit greatly from a catalogue of processes and
chromatin characteristics mapped to particular genomic elements.
For example, the nuclear lamins are thought to influence
chromatin organization, DNA replication and transcription
[47,50]. Our immunoprecipitation results demonstrating that
SWI/SNF components are associated with lamin A/C (Figure7
and Table S10) along with immunoprecipitation, immunolocali-
zation and cell fractionation experiments from others demonstrat-
ing an association between SWI/SNF and nuclear lamina (e.g.
emerin Figure7; [51]) prompted us to investigate whether SWI/
SNF and the lamins can be located to the same genomic
sequences.
Table 5. Significant pathways and biological processes
associated with SWI/SNF union ChIP-Seq regions.
Overrepresented categories for
the SWI/SNF union regions
1
Benjamini-corrected
p-values
KEGG hsa05200:Pathways in cancer 4.7610
28
KEGG hsa05212:Pancreatic cancer 4.9610
23
KEGG hsa05222:Small cell lung cancer 1.7610
23
KEGG hsa05211:Renal cell carcinoma 2.5610
23
KEGG hsa05220:Chronic myeloid leukemia 3.4610
24
KEGG hsa05215:Prostate cancer 8.9610
23
KEGG hsa05210:Colorectal cancer 1.7610
23
KEGG hsa05016:Huntington’s disease 2.1610
24
KEGG hsa05010:Alzheimer’s disease 1.4610
23
KEGG hsa04010:MAPK signaling pathway 1.3610
25
KEGG hsa04012:ErbB signaling pathway 2.6610
23
KEGG hsa04115:p53 signaling pathway 3.4610
24
KEGG hsa04310:Wnt signaling pathway 7.8610
23
KEGG hsa04910:Insulin signaling pathway 8.9610
23
KEGG hsa04070:Phosphatidylinositol
signaling system
7.9610
23
KEGG hsa04120:Ubiquitin mediated proteolysis 8.4610
27
KEGG hsa03040:Spliceosome 8.6610
210
GO:0051056 regulation of small GTPase
mediated signal transduction
1.8610
23
GO:0007049 cell cycle 3.4610
234
GO:0006260 DNA replication 4.5610
210
GO:0051301 cell division 4.1610
218
GO:0006281 DNA repair 5.6610
220
GO:0006915 apoptosis 8.8610
29
GO:0051276 chromosome organization 1.5610
211
GO:0016568 chromatin modification 2.1610
217
GO:0006357 regulation of transcription
from RNA polymerase II promoter
6.1610
27
GO:0034470 ncRNA processing 2.4610
215
GO:0001701 in utero embryonic development 1.5610
25
1 Overrepresented terms were determined using DAVID tools for Ensembl
genes corresponding to the 49,555 SWI/SNF union regions for Benjamini
corrected p-values,0.01. A complete list is available in Table S7.
doi:10.1371/journal.pgen.1002008.t005
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nuclei and performed ChIP-chip on tiling arrays covering the
ENCODE pilot regions (see Materials and Methods and Table
S1). Most of the 1,770 lamin A/C regions mapped to H3K27me3
domains (76%; 1,337/1,770) whereas the 1,270 lamin B regions
were less commonly associated with H3K27me3 (29%; 372/
1,270). Comparing regions where signal was detectable for the
SWI/SNF, lamin A/C and lamin B experiments revealed that
SWI/SNF has a much higher overlap with lamin B than lamin A/
C. We found that 38% (297/784) of SWI/SNF sites are within
100 bp of a lamin B region whereas only 5% (41/784) of SWI/
SNF sites are within 100 bp of a lamin A/C region (Table7). For
both lamin types the colocalization with SWI/SNF regions is
significant relative to random target lists (lamin B, p,1610
216;
lamin A/C, p,1610
215; GSC tests). SWI/SNF-lamin B inter-
secting regions contained approximately the same proportion of
CTCF sites in the ENCODE regions as did all SWI/SNF sites in
the ENCODE regions (p.0.05 hypergeometric test; Table7).
Enhancers are underrepresented in the SWI/SNF-lamin B regions
relative to all SWI/SNF locations in the ENCODE regions
(p,1.9610
236; hypergeometric test). The SWI/SNF-lamin B
regions are overrepresented for Pol II (p,2.9610
239; hypergeo-
metric test) and 59 ends (p,7.3610
237; hypergeometric test)
relative to all SWI/SNF locations in the ENCODE regions.
In crosslinked chromatin SWI/SNF is detected primarily with
lamin B, but as noted from the above mass spectrometry
experiments, in solubilized, non-cross-linked cells SWI/SNF is
detected with lamin A/C and not lamin B (Figure1 and Figure7).
We interpret these results to indicate that SWI/SNF, lamin
A/C and lamin B co-associate in different nuclear contexts but
are all part of a broader interacting network with specific
sub-associations.
Association of SWI/SNF with DNA replication origins
SWI/SNF and the lamins have each been implicated in DNA
replication (see above; [52,53]). One of the proteins we detected as
associated with SWI/SNF is the replication protein RepA and
another regulator of DNA replication, geminin, has been found to
co-purify with SWI/SNF in HeLa cells (Figure7, red circles; [54]).
We investigated whether there might be a relationship among
SWI/SNF, lamins and DNA replication origins. We obtained a set
of 282 DNA replication origins identified in HeLa cells for the
Figure 6. Network of overrepresented and other related KEGG pathways identified using SWI/SNF ChIP-Seq union regions. The
KEGG pathways identified as overrepresented using the 49,555 SWI/SNF ChIP-Seq union regions are shown as yellow nodes and each of their related,
KEGG-designated pathways are also displayed. Pathways related to the overrepresented pathways but that are not overrepresented themselves are
shown as gray nodes. Red edges connect yellow nodes. Three of the nodes, spliceosome, ribosome and RNA degradation, are distinct and unrelated
to other pathways according to the KEGG database. From this analysis three groups of pathways emerged: A) pathways related to signal
transduction, glycan and carbohydrate metabolism, cell growth and death and other cellular processes B) nucleotide and amino acid metabolism and
C) genetic information processing.
doi:10.1371/journal.pgen.1002008.g006
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origins, 90 (32%) occur within 100 bp of a SWI/SNF region
(p,1610
216, GSC test), 86 (31%) occur at the 59 ends of protein-
coding genes and 151 (54%) occur within 100 bp of a lamin B
region. In contrast to lamin B, only 17% (48/282) of the
replication origins were near a lamin A/C region. These results
are consistent with nuclear staining patterns observed in mouse
3T3 cells showing colocalization between lamin B and sites of
DNA replication whereas the same colocalization patterns were
not observed for replication foci and lamin A [52].
Of the 86 replication origins in promoter regions, 88% (76/86)
intersected a lamin B region and most (78% or 67/86) were within
a 100 bp of a SWI/SNF region. These data indicate that SWI/
SNF components are located near many DNA replication origins,
particularly those located in promoter regions. The coincidence of
chromatin remodeling factors, promoters, lamins and replication
origins at the same subset of genomic regions suggests that these
loci may be particularly favorable for the formation of both DNA
and RNA polymerase assembly and chromatin tethering. As
shown in Figure1 the interplay among these elements as well as
with Pol II, CTCF and heterochromatin regions is complex and
interwoven, such that each may share many different supporting
and counteracting roles.
Discussion
SWI/SNF performs a crucial function in gene regulation and
chromosome organization by directly altering contacts between
nucleosomes and DNA. In the work presented here we undertook
a two-pronged approach (ChIP-Seq and IP-mass spectrometry) to
move towards a more thorough understanding of these functions.
Our ChIP-Seq analyses demonstrate that SWI/SNF components
overlap extensively with important regions that require tight
control of the dynamics of nucleosome occupancy such as
promoters, enhancers and CTCF sites. Not only does the SWI/
SNF complex change the accessibility of DNA but it also acts in
concert with an extensive host of cooperating factors, thereby
facilitating combinatorial control among various genomic ele-
ments. In addition to our ChIP-Seq results, the diversity and
number of proteins that co-purify with SWI/SNF as identified in
Figure 7. Network of proteins that have been shown to co-purify with SWI/SNF factors. 158 proteins have been shown to co-purify with
SWI/SNF factors in HeLa cells, either by our IP-mass spectrometry experiments or in other studies. Interactions are annotated in Table S10. As
indicated in the figure key, pink circles denote SWI/SNF components; the larger pink circles are SWI/SNF factors used as bait in this study. Blue edges
denote interactions detected in this study. Yellow edges indicate interactions between SWI/SNF factors themselves that were detected in this study.
Black edges indicate interactions from other published sources. As noted in Table S10, the studies used a variety of biochemical methods and SWI/
SNF factors were either bait or prey. Non-SWI/SNF factors are color-coded according to UniProt keywords [45].
doi:10.1371/journal.pgen.1002008.g007
Diverse Roles and Interactions of SWI/SNF
PLoS Genetics | www.plosgenetics.org 11 March 2011 | Volume 7 | Issue 3 | e1002008our mass spectrometry experiments further supports SWI/SNF’s
involvement with a variety of functionally distinct complexes.
RNA polymerases II and III are extensively colocalized with
SWI/SNF components. Studies of transcription in HeLa cells have
estimated that the number of active RNA II polymerases exceeds
the number of transcriptionally active sites by at least one order of
magnitude, leading to the proposal of ‘‘transcription factories’’ [1–
3]. The number of RNA Pol II transcription factories in HeLa cells
has been estimated between 5,000 and 8,000 where each factory
can be typified by several looped loci, their resulting transcripts and
distal elements such as enhancers. We infer that SWI/SNF regions
are prevalent in transcriptional assemblages and their associated
regulatory loops, given that .90% of our high-confidence union
targets are associated with genic or regulatory regions and that 65%
of Pol III and 84% of Pol II regions colocalize with at least one
SWI/SNF factor (Table4, Tables S5 and S6).
Interestingly we observed that SWI/SNF components often
occur independently of each other and in various configurations
across the genome, and similarly our mass spectrometry data point
to heterogeneity of SWI/SNF complexes. We speculate that
several mechanisms may underlie these various configurations and
their associated genomic features, including 1) synergism or
antagonism of the individual SWI/SNF factors in influencing
expression (e.g. Figure5); 2) failure to detect individual subunits
due to epitope masking as a consequence of variation with local
environments; 3) the capture of incomplete complexes that may in
fact be completed upon superposition of genome-wide 3C data
once such data become available (e.g. Figure4); 4) the existence of
SWI/SNF sub-complexes that deviate from the conventional
composition of SWI/SNF assemblies (e.g. [56]) or 5) the capture of
intermediates in a multistep assembly or remodeling process. This
last view is consistent with a model of stochastic assembly that may
occur through intermediate interactions and that has been
described for several other large, multifactor complexes such as
RNA polymerases and associated transcription factors [57],
spliceosomes [58], and DNA repair complexes [59].
As shown in Figure6 SWI/SNF occurs throughout many
interconnected pathways. The assembly of functional SWI/SNF
complexes at many locations in the genome may require the
activation of one or more of these related pathways. Consequently
some of the SWI/SNF associated regions we observed may reflect
constitutive binding of partially assembled complexes that may be
poised to receive additional signal inputs for subsequent regulatory
activity. Indeed it has been shown that SWI/SNF components are
present at regulatory regions even in the absence of stimulatory
conditions or tissue-specific cofactors. For example Brg1 is present
constitutively at the interferon-inducible genes IFITM3 [60] and
CIITA [30] in unstimulated HeLa cells, which is consistent with
our own finding of Brg1 and Ini1 at IFITM3 and various
combinations of BAF155, BAF170, Ini1 and Brg1 at different
elements in CIITA. In solution SWI/SNF factors are associated
constitutively with RelB (HEK293 cells, [61]), RelA, NFkB1 and
NFkB2 (HeLa cells, this study), the glucocorticoid receptor (T4D7
cells, [62]) and estrogen receptor alpha (HeLa cells, this study and
[42]; SW13 cell extracts, [63]). The prevalence of SWI/SNF and
the high degree of connectivity of its overrepresented pathways
implies that SWI/SNF may assist in many related processes and
may even facilitate crosstalk across many constituents of the
transcriptional machinery. Notably SWI/SNF binds in the genes
of its own subunits (Table S19) suggesting that SWI/SNF may
contribute to auto- and cross-regulation of its subunit levels. Loss-
of-function of a particular subunit, as may occur in certain
cancers, could initiate oscillations and alter the relative abundance
of the levels of the other SWI/SNF subunits through a variety of
feedback and feed-forward loops. Aberrant SWI/SNF expression
has been proposed to result in new combinatorial assemblies of
SWI/SNF, some of which may deleterious [64].
The gene attributes revealed by our ChIP-Seq data substantiate
that SWI/SNF is proximal to targets that comprise sets of
fundamental biological processes. Many of the functional catego-
ries we found to be significantly overrepresented have disease
implications, especially as related to cancer (Figure S2). For
example failures in DNA repair and unchecked cell cycle activity
are common characteristics of pre-cancerous cells, and our SWI/
SNF analyses identified the p53 and MAPK signaling pathways,
which are well known for maintaining checkpoint functions.
Growth dysregulation particularly in the context of hormone
signaling is another common cancer phenotype. Extracellular
growth signals are transduced from the cell membrane to the
nucleus by the ErbB, insulin and phosphtidylinositol signaling
pathways, all of which we recovered as overrepresented (Table5).
The existence of phosphoinositide signaling in the nucleus and the
ability of Brg1 to act as an effector for phosphatidylinositol 4,5-
bisphosphate (PIP2) raises the prospect of several levels of control
of this signaling pathway with respect to SWI/SNF [65], a
hypothesis that can be examined in future studies.
Several of the overrepresented pathways we identified through
our ChIP-Seq analyses share proteins detected in SWI/SNF co-
purification experiments, thereby providing a resource to explore
potential, highly-interactive network structures. For example we
found that genes with products critical for ‘nucleotide excision
repair’ were enriched using our SWI/SNF union list (Figure6).
Within this pathway the excision repair protein ERCC5 co-purified
with both BAF155 and BAF170 in our IP (immunoprecipitation)-
mass spectrometry experiments. The excision repair protein, XPC,
associates with SWI/SNF in response to UV irradiation in HeLa
cells, and BRCA1 and ATR also cooperate withSWI/SNF in DNA
repair(Figure7;TableS10;[66]).ThuswespeculateSWI/SNFmay
participate in DNA repair through both transcriptional regulation
as well as recruitment to regions undergoing repair.
Table 6. Over-represented annotations from proteins
identified as co-purifying with SWI/SNF in this study.
Overrepresented categories for SWI/SNF
co-associated proteins
1
Benjamini-corrected
p-values
GO:0007049 cell cycle 3.8610
24
GO:0000279 M phase 2.8610
24
GO:0015630 microtubule cytoskeleton 8.4610
24
GO:0006323 DNA packaging 7.9610
23
GO:0000793 condensed chromosome 8.1610
23
GO:0051276 chromosome organization 9.9610
23
GO:0006333 chromatin assembly or
disassembly
1.0610
22
GO:0005813 centrosome 1.2610
22
GO:0034728 nucleosome organization 1.5610
22
GO:0005815 microtubule organizing center 2.2610
22
GO:0016584 nucleosome positioning 2.8610
22
GO:0000777 condensed
chromosome kinetochore
2.9610
22
Overrepresented terms were determined using DAVID for Ensembl genes
corresponding to the 101 proteins we identified as co-associated with a SWI/
SNF factor as determined by IP-mass spectrometry. We considered Benjamini-
corrected p-values,0.05. A complete list is available in Table S8.
doi:10.1371/journal.pgen.1002008.t006
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collect a SWI/SNF interaction network. We limited our network to
a single model system, HeLa cells, because many attributes of SWI/
SNF have been documented in these cells and it has been noted that
SWI/SNF associations vary by cell type [67]. We extensively
collated SWI/SNF protein interactions described in the literature.
This undertaking was necessary because many of the proteins
described in the literature as co-associated with SWI/SNF factors
are not represented in interaction databases such as BioGRID,
Molecular Interactions Database (MINT), IntAct, Human Protein
Reference Database (HPRD), Nuclear Protein Database (NPD) and
Interologous Interaction Database (I2D). Therefore we attempted
to comprehensively collect such information to overcome these
limitations. In total 158 SWI/SNF interacting proteins have been
described in HeLa cells (Figure8 and Table S10), which is similar to
the number of SWI/SNF interacting proteins that have been
described in other cell types [67]. Published molecular associations
that werenot discernedheremightbe duetointeractionsthatare:1)
transient or of low affinity, 2) dependent on a specific set of
biochemical conditions or 3) undetectable due to masking by the
presence of more abundant protein(s) of similar size. In working
with protein interaction data, similar degrees of overlap have been
notedwhen comparisonsaremade acrossdata sets[68,69]and even
in a well-studied model such as yeast, mass spectrometry analyses
have found a plasticity of complexes and many previously
undetected interactions [70–72]. From the ChIP-Seq and ChIP-
chip results we expected that CTCFand lamin B may be among the
proteins that co-associate with SWI/SNF, however neither of these
factors was recovered in any of the non-directed experiments (Table
S10), including a CTCF immunoprecipitation-mass spectrometry
experiment performed in HeLa cells. In addition to the above
considerations one possibility is that CTCF or lamin B may
associate more strongly with one of the SWI/SNF factors not
studied, e.g. BAF53A or one of the BAF60 subunits.
Figure 8. Histogram showing the frequencies of UniProt keywords for proteins that co-purify with SWI/SNF factors. Keywords shown
were retrieved from the UniProt database [45] for proteins that co-purify with a SWI/SNF factor, as annotated in Table S10.
doi:10.1371/journal.pgen.1002008.g008
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context however data derived from a variety of sources suggests
that SWI/SNF has other facets. It is possible that not all of SWI/
SNF’s functions involve DNA localization and therefore other
types of global experiments, such as the IP-mass spectrometry, are
valuable as first steps towards recognizing previously unknown
roles. Unlike cytoplasmic compartments, nuclear compartments
are not separated by a physical barrier but rather are functional
assemblies that are typically organized around sets of molecules
engaged in common functions. Data from both ChIP-Seq and IP-
mass spectrometry illuminate the sectors in which SWI/SNF
operates and the integration of these two methods is better than
each alone for furnishing a broad comprehension of SWI/SNF
action. For example ChIP-Seq enables the global identification of
SWI/SNF chromosomal elements except for those regions with
highly repetitive sequence such as human centromeres (Figure2A).
In this respect IP-mass spectrometry is complementary to ChIP-
Seq because it strongly suggests that SWI/SNF occurs at
kinetochores as evidenced by its co-purification with CENPE,
NUF2, BUB1B and CLASP2 (Figure7 and Figure9). In addition to
kinetochore proteins the SWI/SNF co-purification experiments
also uncovered proteins from other substructures including
centrosomes, microtubules, the nuclear periphery and PML
nuclear bodies, the latter of which is characterized by cryptic foci
of PML (promyelocytic leukemia protein) and has been implicated
in a variety of diseases [73]. The ChIP-Seq and IP-mass
spectrometry data are synergistic as well. Notably both methods
found an overrepresentation of regions or proteins enriched for
‘cell cycle’ and ‘chromosome organization’. One possible inference
from these studies is that SWI/SNF is well positioned to integrate
signals across multiple signaling pathways both by its presence in a
variety of cellular structures and its role in gene regulation through
chromatin remodeling.
A fraction of SWI/SNF complexes co-associate with elements of
the nuclear periphery where they are well situated to contribute to
the nuclear organization and position-dependent gene expression
(Figure7; [74]). We found that in crosslinked cells SWI/SNF
localizes more widely with lamin B than lamin A whereas in non-
crosslinked cells SWI/SNF co-purifies with lamin A. As mentioned
above lamin B may have escaped detection in SWI/SNF protein
interaction studies. A related possibility is that SWI/SNF may exist
in different nuclear pools that have varying solubilities and
associations, such that recovery of particular SWI/SNF complexes
depends upon the proteins with which SWI/SNF is associated. For
example lamins A and B are known to have different
nucleoplasmic mobilities and localization patterns [50,52]. Immu-
nolocalization experiments in HeLa nuclei have revealed that the
A/C- and B-type lamins form distinct meshworks with occasional
points of intersection [50], which is consistent with the interspersed
patterns of lamin A/C and B that we detected (Figure1). Hence it
is reasonable to expect that SWI/SNF associated with lamin A
would behave differently than when associated with lamin B. We
surmise that in a chromatin context the dominant association of
SWI/SNF with the nuclear lamins occurs in regions where lamin
B is present. The purification of SWI/SNF with lamin A may
indicate other biological roles, such as cell cycle progression or
nuclear assembly [75,76].
Gaining a more detailed understanding of SWI/SNF’s activities
in or near various heterochromatin environments will be central to
comprehending nuclear events over the cell cycle as well as during
development. Among the numerous molecular and epigenetic
factors that have been found to affect heterochromatin formation
or maintenance, the heterochromatin protein 1 alpha (HP1a, also
known as CBX5; Figure7) and Polycomb complexes (PcG) are of
particular relevance to SWI/SNF [77–79]. Polycomb complexes
promote gene silencing by catalyzing the trimethylation of H3K27
in its target regions, and SWI/SNF antagonizes this epigenetic
silencing [80]. It is tempting to speculate that SWI/SNF found
near the edges of H3K27me3 domains (Figure1A and 1C) may be
contributing to the establishment or maintenance of boundary
elements. SWI/SNF may also engage in heterochromatin
dynamics through its interaction with HP1a, which is often
located in the centromeric regions (reviewed in [81]). Curiously
HP1a interacts with the lamin B receptor [82] thus providing a
potential bridge between heterochromatin and the inner nuclear
membrane. Both H3K27me3 and lamin B are associated with
spatially regulated genes whose conversion between active and
inactive states depends on access to their regulatory regions, as
may be conferred by SWI/SNF.
The work presented here provides new insights into the scope of
SWI/SNF’s influence in gene regulation and nuclear organization.
The integration of numerous studies is beginning to reveal the
complexities contributing to the regulation of any given locus.
Contemporary models of transcriptional control propose that a
series of factors transiently associate with a regulatory region
before a decisive event tilts these intermediate reactions towards a
productive outcome [57,83]. SWI/SNF may contribute to such
intermediate reactions or trigger switches between inactive and
active states. The capacity for SWI/SNF to preserve many aspects
of homeostasis also makes it vulnerable to being ensnared for
aggressive cell proliferation. Our work demonstrates that SWI/
SNF in particular and perhaps chromatin remodeling proteins in
general will contribute unique insights to our understanding of
gene regulation and disease mechanisms through the integration of
target regions, spatial positioning and functional annotations. For
example the co-occurrence of SWI/SNF with centrosomes,
microtubules, kinetochores and the nuclear periphery may suggest
that a pool of SWI/SNF is sequestered by these structures during
mitosis to assist in the post-mitotic reformation of chromosomal
territories. Our collective findings help inform a comprehensive
view of SWI/SNF function as well as form a valuable
compendium for future studies of nuclear functions as related to
chromatin remodeling.
Table 7. Co-occurrence of SWI/SNF factors and lamins in the
ENCODE regions.
Lamin A/C
1 Lamin B
2 SWI/SNF
3
Ini1 22 (54%) 186 (63%) 598 (76%)
Brg1 6 (15%) 75 (25%) 204 (26%)
BAF155 31 (76%) 216 (73%) 588 (75%)
BAF170 23 (56%) 155 (52%) 394 (50%)
CTCF 7 (17%) 60 (20%) 146 (19%)
Enhancers 8 (20%) 32 (11%) 289 (37%)
RNA Pol II 23 (56%) 214 (72%) 335 (43%)
59 Ends 15 (37%) 186 (63%) 274 (35%)
59 Ends, expressed 12 (29%) 128 (43%) 93 (12%)
59 Ends, not
expressed
4 (10%) 66 (22%) 191 (24%)
1 A total of 41 SWI/SNF regions intersect a lamin A/C region.
2 A total of 297 SWI/SNF regions intersect a lamin B region.
3 There are 784 SWI/SNF high-confidence union regions that were used for
comparison with lamin ChIP-chip array data.
doi:10.1371/journal.pgen.1002008.t007
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Chromatin immunoprecipitations
Suspension HeLa S3 cells were cultured by the National Cell
Culture Center (Biovest International Inc., Minneapolis, MN) in
modified minimal essential medium (MEM), supplemented with
10% FBS at 37uCi n5 %C O 2, to a density of 6610
5 cells/mL.
Cells were fixed with 1% formaldehyde at room temperature for
10 min. Fixation was terminated with 125 mM glycine (2 M stock
made in 1x PBS). Formaldehyde-fixed cells were washed in cold
Dulbecco’s PBS (Invitrogen) and swelled on ice in a 10-mL
hypotonic lysis buffer [20 mM Hepes (pH 7.9), 10 mM KCl,
1 mM EDTA (pH 8.0), 10% glycerol, 1 mM DTT, 0.5 mM
PMSF, and Roche Complete protease inhibitors, Cat#1697498].
To isolate nuclei, whole cell lysates were homogenized with 30
strokes in a 7 mL Dounce homogenizer (Kontes, pestle B).
Nuclear pellets were collected by centrifugation and lysed in
10 mL of RIPA buffer per 3610
8 cells [RIPA buffer: 10 mM Tris-
Cl (pH 8.0), 140 mM NaCl, 1% Triton X-100, 0.1% SDS, 1%
deoxycholic acid, 0.5 mM PMSF, 1 mM DTT, and protease
inhibitors]. Chromatin was sheared with an analog Branson 250
Sonifier (power setting 2, 100% duty cycle for 7630-s intervals) to
an average size of less than 500 bp, as verified on a 2% agarose
gel. Lysates were clarified by centrifugation at 20,0006 g for
15 min at 4uC.
Clarified nuclear lysates from 1610
8 cells were agitated
overnight at 4uC with 20 mg of one of the following antibodies:
1) anti-Ini1 (C-20), Santa Cruz Biotechnology, sc-16189; 2) anti-
BAF155 (H-76), Santa Cruz Biotechnology, sc-10756; 3) anti-
BAF170 (H-116), Santa Cruz Biotechnology, sc-10757; 4) anti-
Brg1 (G-7), Santa Cruz Biotechnology, sc-17796; 5) anti-lamin A/
C (H-110), Santa Cruz Biotechnology, sc-20681; 6) anti-lamin B
antibody, EMD Biosciences, NA12; or 7) normal IgG, Santa Cruz
Biotechnology, sc-2025. Antibody incubations were followed by
addition of either protein A (Millipore #16-156) or protein G
agarose beads (Millipore #16-266). Beads were permitted to bind
to protein complexes for 60 min at 4uC. Immunoprecipitates were
washed three times in 1x RIPA, once in 1x PBS, and then eluted
in 1xTE/1%SDS. Crosslinks were reversed overnight at 65uC.
ChIP DNA was purified by incubation with 200 mg/ml RNase A
(Qiagen #19101) for 1 h at 37uC, with 200 mg/ml proteinase K
(Ambion AM2548) for 2 h at 45uC, phenol:chloroform:isoamyl
alcohol extraction, and precipitation with 0.1 volumes of 3 M
sodium acetate, 2 volumes of 100% ethanol and 1.5 mL of pellet
paint (Novagen #69049-3). ChIP DNA prepared from
1610
8 cells was resuspended in 50 mL of Qiagen Elution Buffer
(EB). Three biological replicates were prepared per antibody.
Construction and sequencing of Illumina libraries
ChIP-Seq libraries were prepared and sequenced as previously
described [26,84]. Biological replicates for each factor were
converted into separate and distinct libraries. To summarize,
ChIP DNA samples were loaded onto Qiagen MinElute PCR
columns, eluted with 15 mL of Qiagen buffer EB, size-selected in
the 100–350 bp range on 2% agarose E-gels (Invitrogen) and gel-
purified using a Qiagen gel extraction kit. DNA was end-repaired
and phosphorylated with the End-It kit from Epicentre (Cat#
ER0720). The blunt, phosphorylated ends were treated with
Klenow fragment (39 to 59 exo minus; NEB, Cat# M0212s) and
dATP to yield a protruding 39-‘A’ base for ligation of Illumina
adapters (100 RXN Genomic DNA Sample Prep Oligo Only Kit,
Part# FC-102-1003), which have a single ‘T’ base overhang at the
39 end. After adapter ligation (LigaFast, Promega Cat# M8221)
DNA was PCR-amplified with Illumina genomic DNA primers
1.1 and 2.1 for 15 cycles by using a program of (i) 30 s at 98uC, (ii)
15 cycles of 10 s at 98uC, 30 s at 65uC, 30 s at 72uC, and (iii) a
5 min extension at 72uC. The final libraries were band-isolated
from an agarose gel to remove residual primers and adapters.
Figure 9. Illustration showing overrepresented GO ‘‘cellular component’’ categories for SWI/SNF co-purifying proteins.
Overrepresented GO ‘‘cellular component’’ categories are displayed for proteins we detected by IP-mass spectrometry. Centrosomal proteins are
shaded brown, chromosomal proteins are blue, kinetochore proteins are orange and cytoskeletal proteins are green. Genes encoding starred proteins
are targets of SWI/SNF as identified by ChIP-Seq. Based on these annotations SWI/SNF is associated with multiple cellular components.
doi:10.1371/journal.pgen.1002008.g009
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UV-Vis spectrometry on a NanoDrop ND-1000 spectrophotom-
eter (Thermo Fisher Scientific). Purified and denatured library
DNA was capture on an Illumina flowcell for cluster generation
and sequenced on an Illumina Genome Analyzer II following the
manufacturer’s protocols [85].
Identification of proteins by mass spectrometry
Immunoprecipations were performed using the same conditions as
for ChIP experiments except the HeLa S3 cells were not crosslinked.
In addition to the ChIP antibodies described above we also used anti-
Brm, Abcam Cat# ab15597 and anti-BAF250a (PSG3), Santa Cruz
Biotechnology, sc-32761. Complexes were resolved on BioRad
4–20% precast Tris-HCl gels (Cat#161-1159) such that a single
gel was used for each specific antibody and normal IgG
immunoprecipitation pair. Gels were silver stained using Pierce
SilverSNAP stain for mass spectrometry (Cat#24600) and each lane
was excised into 10–12 molecular weight regions. Gel slices were
destained, dried in a Savant speed-vac and digested overnight at
42uC with Sigma’s Trypsin Profile IGD kit for in-gel digests (Cat#
PP0100). Following the overnight incubation the liquid was removed
from each gel piece and volume reduced by drying to approximately
10 mL. The individual gel slices were analyzed separately.
Mass spectrometry
The samples were subjected to nanoflow chromatography using
nanoAcquity UPLC system (Waters Inc.) prior to introduction into
the mass spectrometer for further analysis. Mass spectrometry was
performed on a hybrid ion trap LTQ Orbitrap mass spectrometer
(Thermo Fisher Scientific) in positive electrospray ionization (ESI)
mode. The spectra was acquired in a data dependent fashion
consisting of full mass spectrum scan (300–2000 m/z) followed by
MS/MS scan of the 3 most abundant parent ions. For the full scan
in the orbitrap the automatic gain control (AGC) was set to 1610
6
and the resolving power for 400 m/z of 30,000. The MS/MS
scans were done using the ion trap part of the mass spectrometer
at a normalized collision energy of 24 V. Dynamic exclusion time
was set to 100 s to avoid loss of MS/MS spectral information due
to repeated sampling of the most abundant peaks.
Sequence data from MS/MS spectra was processed using the
SEQUEST database search algorithm (Thermo Fisher Scientific).
The resulting protein identifications were brought into the Scaffold
visualization software (Proteome Software) where the information
was further refined resulting in improved protein id conformation.
Scaffold search criteria were set at 98% probability and required
at least 2 unique peptides per id.
Determination of enriched regions in SWI/SNF ChIP-Seq
data
All ChIP-Seq data sets (Ini1, Brg1, BAF155, BAF170, and Pol II)
were scored against a normal IgG control using PeakSeq [26] with
default parameters (q-value,0.05) to determine an initial set of
enriched regions. These lists were then filtered by removing those
regions that did not meet all of the following requirements: 1) the
q-value from PeakSeq wasfurther restrictedtoa q-value of,0.01; 2)
a minimum of 20 sequencing reads per peak from the specific
antibody ChIP; 3) an enrichment of 1.5-fold of the specific antibody
relative to the normal IgG control; and 4) an excess of at least 10 of
the specific antibody reads relative to the normal IgG control reads.
Enriched regions satisfying these criteria comprised our initial list of
enrichment sites for each factor (Table1 and Tables S11, S12, S13,
S14, S15, and S16). Among these data sources, Pol II and the
normal IgG control have been published as part of prior studies
and are available in GEO (accession numbers GSE14022 and
GSE12781, respectively) [26,84]. Data for Ini1, Brg1, BAF155 and
BAF170 can be accessed through GEO series GSE24397.
Generation of a SWI/SNF union list from ChIP-Seq results
After obtaining our initial list of enriched regions for each factor
subjected to chromatin immunoprecipitation, we generated a union
list of SWI/SNF component targets. Using the method described in
Euskirchen et al. [86], we formed the union of Ini1, BAF155,
BAF170, and Brg1 enriched regions as identified by ChIP-Seq and
merged any unioned regionsthat were separated by #100 bp. Each
union region was then classified by whether it intersected with one
or more of BAF155, BAF170, Ini1, and Brg1. The resulting list
consists of 69,658 SWI/SNF union regions (Table S2).
Determination of the ‘‘high-confidence’’ and ‘‘core’’ SWI/
SNF regions from the ChIP-Seq union regions
We compared our ChIP-Seq target lists for the 69,658 SWI/
SNF union regions against genomic features at which chromatin
remodeling is expected to play a prominent role: RNA polymerase
II sites [26], 59 ends of Ensembl protein-coding genes, CTCF sites
[28], and regions predicted to be enhancers in HeLa cells [29]. We
also compared individual SWI/SNF component lists against each
other. Only those SWI/SNF regions which intersect another
SWI/SNF component or which intersect at least one of the above
genomic features were retained for the ‘high-confidence’ union list.
For gene promoter regions, we define overlap as a target region
with at least 1 shared bp within 62.5 kb of the annotated
transcription start site (TSS). SWI/SNF region intersections were
calculated both for all genes in the Ensembl 52 database build
using annotations from NCBI36 (human genome build hg18) as
well as for a subset of genes that Ensembl identifies as protein-
coding. The resulting target list consists of 49,555 ‘high-
confidence’ SWI/SNF union regions (Table S3). Union regions
containing all three of the BAF155, BAF170, and Ini1 subunits are
designated as the 9,760 ‘core’ SWI/SNF regions (Table3).
Generating co-occurrence tables
To determine the co-occurrences of features of interest we used
a similar intersection strategy as was used for determining the
high-confidence SWI/SNF regions. For all pairwise comparisons,
one of the two data sets was extended by 100 bp on each side of
the region and then intersected against the other, non-extended
dataset. We required an overlap of at least 1 bp to deem two
regions as associated. Using a Perl script, the intersection results
for all comparisons were combined to form the co-occurrence
table. The same procedure was followed to generate SWI/SNF-
centric (Tables S2 and S3), Pol II-centric (Table S5) and Pol III-
centric (Table S6) co-occurrence tables.
Determination of expressed regions
Using the HeLa RNA-Seq data of Morin et al. [37], we
subdivided each list by the expression status of the corresponding
gene targets. Expressed genes were defined as any Ensembl gene
with an associated Ensembl transcript having an adjusted depth of
$1, representing an average coverage of 1x across all bases in the
transcript. A total of 9,711 expressed protein-coding genes satisfied
these criteria.
Comparison of expression levels associated with different
SWI/SNF sub-complexes
We created a series of lists based upon the combinations of
SWI/SNF components that could co-occur using the 49,555 high-
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RNA-Seq data of Morin et al. [37], we intersected each list against
the 59 ends of transcripts queried by that study and recorded the
corresponding adjusted depth for any transcript with a 59 end
within 62.5 kb of a SWI/SNF region. Morin et al. treats adjusted
depth as a measurement of transcription level for the correspond-
ing transcript. For each list, these measurements were used to
build a series of violin plots showing the probability distribution of
transcription levels associated with different compositions of SWI/
SNF subunits. Note that each SWI/SNF region from Table S2
can only be assigned to one list (e.g. a region containing BAF155,
BAF170, and Ini1 is not also assigned to the list of regions
containing BAF155 and BAF170).
Pathway analyses of SWI/SNF factors
Overrepresented GO categories [87] and KEGG pathways [88]
were determined using DAVID tools [16]. Figures S2 and S3 were
drawn using KGML-ED [89].
ChIP-chip experimental procedures and array scoring
The ENCODE tiling arrays (NimbleGen Systems Inc.,
Madison, WI) interrogate the regions from the pilot phase of the
ENCODE project [90] and tile the non-repetitive forward strand
DNA sequence with 50-mer oligonucleotides spaced every 38 bp
(overlapping by 12 bp) for a total of approximately 390,000
features. For array hybridizations ChIP DNA samples from
1610
8 cells were labeled according to the manufacturer’s protocol
by Klenow random priming with Cy5 nonamers (lamin A/C or
lamin B ChIP DNA) or Cy3 nonamers (normal IgG ChIP DNA).
Biological replicates, defined as ChIP DNA isolations prepared
from distinct cell cultures, were each hybridized to separate
microarrays. Each lamin data set consists of three biological
replicates. ChIP DNA labeling and array hybridizations were
conducted by the NimbleGen service facility (Reykjavik, Iceland).
Briefly, arrays were hybridized in Maui hybridization stations for
16–18 h at 42uC, and then washed in 42uC 0.2% SDS/0.2x SSC,
room temperature 0.2x SSC, and 0.05x SSC. Arrays were scanned
on an Axon 4000B scanner.
For each pair of arrays the files (in GFF file format) corres-
ponding to the two channels for ChIP DNA (635 nm) and
reference DNA (532 nm), were uploaded to the TileScope pipeline
for normalization and scoring [91]. Data were scored with the
following TileScope program parameters: quantile normalization
of replicates, iterative peak identification, window size=500, oligo
length=50, pseudomedian threshold=1.0, p-value thresh-
old=4.0, peak interval=1000, and feature length=1000. Regions
called by Tilescope were then filtered and corrected for multiple
hypothesis testing by false discovery rate (FDR). To generate our
set of background regions for FDR analysis, we randomly shuffle
the probe values within each replicate, ensuring that the same
probes are swapped for each replicate. This shuffled data set is
then used as input to Tilescope and the scores compared against
the lamin A/C and the lamin B data sets. The final lists of
enriched regions for lamin A/C and lamin B have a final FDR of
0.1. Target coordinates were converted to hg18 using the UCSC
‘liftOver’ utility (http://genome.ucsc.edu/cgi-bin/hgLiftOver).
Lamin A/C and lamin B data are available through GEO series
GSE24382 and Tables S17 and S18.
Comparison of features across the ENCODE regions
To facilitate comparisons between sequencing and array data we
retained only those regions that could be queried by both platforms.
To this end, we first identified sequences represented on the
ENCODE tiling array that possess less than 25% mappability in
ChIP-Seq experiments using 30 bp reads. Any enriched regions in
the lamin A/C and the lamin B data sets that were entirely
contained within these regions of low mappability were removed
from our lists, as corresponding signal levels are unlikely to be
detected accurately via ChIP-Seq. Mappability was determined
using a 30 bp read length and reported in 100 bp windows
according to [26]. The end result is a list of lamin A/C and lamin B
enriched regions identified by ChIP-chip in areas of the genome
that can be queried by ChIP-Seq. Accordingly, regions that are not
represented on the ENCODE tiling arrays were also removed from
our SWI/SNF ChIP-Seq experiments for this comparison. Because
our ChIP-Seq data covers the entire genome, we began by
restricting our enriched SWI/SNF regions only to those that occur
in the ENCODE pilot regions. We further refined our ChIP-Seq
data set by discarding any SWI/SNF regions that occur in a region
of the tiling array for which a signal level of 0 was observed via
ChIP-chip. Onceour SWI/SNF, lamin A/C, and lamin B lists were
limited to those regions that could be queried by both platforms, we
intersected the remaining lamin regions and the SWI/SNF regions
using the same method that generated the all features table for
enhancers, Pol II, and other elements, as described above. Similar
procedures were followed for intersections with DNA replication
origins identified in the ENCODE regions using tiling arrays [55].
Evaluating enrichment of SWI/SNF components with
respect to other genomic features
To determine whether SWI/SNF components, core regions,
and union regions are enriched for factors such as enhancers, small
RNAs, lamin A/C and B, CTCF sites, Pol II regions, Pol III sites,
59 ends and DNA replication origins, we used the genome
structure correction test (GSC). This test determines the
significance of observations where there ‘‘exists a complex
dependency structure between observations’’ and was specifically
designed for large-scale genomic studies [27]. Given two lists of
genomic regions to compare and a list of coordinates defining
the overall sample space (i.e. the length of each chromosome), a
p-value for the significance of the overlap of the two lists is
calculated and we report this value where noted.
Data deposition
All data produced for this study can be accessed through GEO
and accession numbers for individual series are provided in the
relevant sections. Alternatively, data from the lamin ChIP-chip
experiments and the Ini1, Brg1, BAF155, and BAF170 ChIP-Seq
experiments can be accessed through GEO using the SuperSeries
accession number GSE24398.
Supporting Information
Figure S1 SWI/SNF signals and target regions in the context of
interferon receptor genes onchromosome21. The coordinatesshown
are in hg18 and all regions wereidentified in HeLa cells as detailed in
Table S1 and Materials and Methods. The vertical axis for each
signal track is the count of the number of overlapping DNA
fragments at each nucleotide position and is scaled from 0 to 40 for
each track. Panel A displays a ,3 7 0k br e g i o no nc h r o m o s o m e2 1
containing genes encoding cytokine receptors. Panel B displays a
,20 kb region at the edge of a H3K27me3 domain. Panels C and D
each display ,6 kb regions around the 59 ends of expressed genes.
(EPS)
Figure S2 SWI/SNF ChIP-Seq targets and interacting proteins
superimposed on KEGG ‘Pathways in Cancer’. The KEGG
‘Pathways in Cancer’ network was among those pathways overrep-
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(Benjamini adjusted p-value,4.7610
28). SWI/SNF ChIP-Seq
targets are highlighted in yellow and SWI/SNF co-purifying proteins
detected in our IP-mass spectrometry experiments are highlighted in
blue. SWI/SNF co-purifying proteinsreported inother studies (Table
S10) are highlighted in red. Proteins or genes not detected in any
known SWI/SNF studies are gray. Starred annotations weredetected
in both ChIP-Seq and protein interaction studies.
(EPS)
Figure S3 SWI/SNF ChIP-Seq targets and interacting proteins
superimposed on KEGG ‘Cell Cycle’. The KEGG ‘Cell Cycle’
network was among those pathways overrepresented using the
49,555 SWI/SNF high-confidence union regions (Benjamini
adjusted p-value,3.7610
28). SWI/SNF ChIP-Seq targets are
highlighted in yellow and SWI/SNF co-purifying proteins
detected in our IP-mass spectrometry experiments are highlighted
in blue. SWI/SNF co-purifying proteins reported in other studies
(Table S10) are highlighted in red. Starred annotations were
detected in both ChIP-Seq and protein interaction studies.
(EPS)
Table S1 Data sources.
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Table S2 Features associated with the full union list of 69,658
SWI/SNF ChIP-Seq targets.
(TXT)
Table S3 Features associated with the high-confidence union list
of 49,555 SWI/SNF ChIP-Seq targets.
(XLS)
Table S4 Combinations of features associated with the 49,555
SWI/SNF ChIP-Seq targets from the union list. For each feature,
1=present and 0=absent. The order of features is: 1) Ini1 2) Brg1
3) BAF155 4) BAF170 5) RNA Pol II 6) CTCF 7) Enhancers 8)
Five-prime ends 9) Five-prime end-expressed 10) Five-prime ends,
non-expressed.
(TXT)
Table S5 Features associated with the 23,320 RNA Polymerase
II ChIP-Seq targets.
(XLS)
Table S6 Features associated with the 478 RNA Polymerase III
ChIP-Seq targets.
(XLS)
Table S7 Number of transcripts associated with SWI/SNF
sub-complexes
(XLS)
Table S8 Complete lists of Ensembl gene IDs and overrepre-
sented pathways associated with the 49,555 SWI/SNF ChIP-Seq
union regions.
(XLS)
Table S9 Complete lists of Ensembl gene IDs, peptides and
overrepresented pathways resulting from mass spectrometry of
immunoprecipitated proteins.
(XLS)
Table S10 Data sources and brief description of interactions
displayed in Figure7.
(XLS)
Table S11 Chromosomal coordinates of the 49,458 Ini1 regions.
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Table S12 Chromosomal coordinates of the 46,412 BAF155
regions.
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Table S13 Chromosomal coordinates of the 30,136 BAF170
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Table S14 Chromosomal coordinates of the 12,725 Brg1
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Table S15 Chromosomal coordinates of the 49,555 SWI/SNF
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Table S16 Chromosomal coordinates of the 23,320 RNA
Polymerase II regions.
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Table S17 Chromosomal coordinates of the 1,770 lamin A/C
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Table S18 Chromosomal coordinates of the 1,270 lamin B
regions.
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